Bioventus Inc.
BVS
$8.61
$0.101.12%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.11M | 14.76M | 3.16M | 7.46M | -2.64M |
| Total Depreciation and Amortization | 11.21M | -14.02M | 11.40M | 12.05M | 11.87M |
| Total Amortization of Deferred Charges | -- | 3.63M | -- | -- | -- |
| Total Other Non-Cash Items | 4.79M | 27.39M | 4.86M | 5.95M | 2.64M |
| Change in Net Operating Assets | -10.18M | 6.21M | 10.68M | 477.00K | -31.20M |
| Cash from Operations | 8.93M | 37.97M | 30.10M | 25.94M | -19.33M |
| Capital Expenditure | -574.00K | -580.00K | -473.00K | -683.00K | -826.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 0.00 | 0.00 | -686.00K | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -574.00K | -580.00K | -473.00K | -1.37M | -826.00K |
| Total Debt Issued | -- | 0.00 | 61.91M | 0.00 | 15.00M |
| Total Debt Repaid | -22.00M | -28.75M | -15.30M | -5.00M | -5.00M |
| Issuance of Common Stock | 120.00K | 511.00K | 96.00K | 1.32M | 150.00K |
| Repurchase of Common Stock | -1.04M | 0.00 | -9.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.00K | -208.00K | -66.67M | -10.98M | -9.20M |
| Cash from Financing | -23.14M | -28.45M | -19.98M | -14.66M | 947.00K |
| Foreign Exchange rate Adjustments | -608.00K | 133.00K | -394.00K | 202.00K | 430.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.39M | 9.07M | 9.25M | 10.11M | -18.78M |